Selected research
Industry Research
EGFR Antibody Industry Research Report 2026
Market perspective
The global EGFR Antibody market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for EGFR Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for EGFR Antibody is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for EGFR Antibody is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of EGFR Antibody include Atlas Antibodies, Bethyl, Bio X Cell, BioLegend, Bio-Rad, Everest Biotech, EXBIO, FineTest and Miltenyi Biotec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global EGFR Antibody market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
EGFR Antibody Market by Company
Atlas Antibodies
Bethyl
Bio X Cell
BioLegend
Bio-Rad
Everest Biotech
EXBIO
FineTest
Miltenyi Biotec
Santa Cruz Biotechnology
Merck
EGFR Antibody Segment by Type
Polyclonal
Monoclonal
EGFR Antibody Segment by Application
Immunohistochemistry
Immunofluorescence
Enzyme Linked Immunosorbent Assay
Flow Cytometry
Western Blot
Others
EGFR Antibody Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EGFR Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of EGFR Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EGFR Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of EGFR Antibody manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of EGFR Antibody by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of EGFR Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polyclonal
- Monoclonal
Applications
- Immunohistochemistry
- Immunofluorescence
- Enzyme Linked Immunosorbent Assay
- Flow Cytometry
- Western Blot
- Others
Companies covered
- Atlas Antibodies
- Bethyl
- Bio X Cell
- BioLegend
- Bio-Rad
- Everest Biotech
- EXBIO
- FineTest
- Miltenyi Biotec
- Santa Cruz Biotechnology
- Merck
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global EGFR Antibody Market Size (2021-2032)
- 2.2.2 Global EGFR Antibody Sales (2021-2032)
- 2.2.3 Global EGFR Antibody Market Average Price (2021-2032)
- 2.3 EGFR Antibody by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Polyclonal
- 2.3.3 Monoclonal
- 2.4 EGFR Antibody by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Immunohistochemistry
- 2.4.3 Immunofluorescence
- 2.4.4 Enzyme Linked Immunosorbent Assay
- 2.4.5 Flow Cytometry
- 2.4.6 Western Blot
- 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global EGFR Antibody Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global EGFR Antibody Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global EGFR Antibody Revenue of Manufacturers (2021-2026)
- 3.4 Global EGFR Antibody Average Price by Manufacturers (2021-2026)
- 3.5 Global EGFR Antibody Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of EGFR Antibody, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of EGFR Antibody, Product Type & Application
- 3.8 Global Manufacturers of EGFR Antibody, Established Date
- 3.9 Global EGFR Antibody Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Atlas Antibodies
- 4.1.1 Atlas Antibodies Company Information
- 4.1.2 Atlas Antibodies Business Overview
- 4.1.3 Atlas Antibodies EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Atlas Antibodies EGFR Antibody Product Portfolio
- 4.1.5 Atlas Antibodies Recent Developments
- 4.2 Bethyl
- 4.2.1 Bethyl Company Information
- 4.2.2 Bethyl Business Overview
- 4.2.3 Bethyl EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bethyl EGFR Antibody Product Portfolio
- 4.2.5 Bethyl Recent Developments
- 4.3 Bio X Cell
- 4.3.1 Bio X Cell Company Information
- 4.3.2 Bio X Cell Business Overview
- 4.3.3 Bio X Cell EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bio X Cell EGFR Antibody Product Portfolio
- 4.3.5 Bio X Cell Recent Developments
- 4.4 BioLegend
- 4.4.1 BioLegend Company Information
- 4.4.2 BioLegend Business Overview
- 4.4.3 BioLegend EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BioLegend EGFR Antibody Product Portfolio
- 4.4.5 BioLegend Recent Developments
- 4.5 Bio-Rad
- 4.5.1 Bio-Rad Company Information
- 4.5.2 Bio-Rad Business Overview
- 4.5.3 Bio-Rad EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bio-Rad EGFR Antibody Product Portfolio
- 4.5.5 Bio-Rad Recent Developments
- 4.6 Everest Biotech
- 4.6.1 Everest Biotech Company Information
- 4.6.2 Everest Biotech Business Overview
- 4.6.3 Everest Biotech EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Everest Biotech EGFR Antibody Product Portfolio
- 4.6.5 Everest Biotech Recent Developments
- 4.7 EXBIO
- 4.7.1 EXBIO Company Information
- 4.7.2 EXBIO Business Overview
- 4.7.3 EXBIO EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 EXBIO EGFR Antibody Product Portfolio
- 4.7.5 EXBIO Recent Developments
- 4.8 FineTest
- 4.8.1 FineTest Company Information
- 4.8.2 FineTest Business Overview
- 4.8.3 FineTest EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 FineTest EGFR Antibody Product Portfolio
- 4.8.5 FineTest Recent Developments
- 4.9 Miltenyi Biotec
- 4.9.1 Miltenyi Biotec Company Information
- 4.9.2 Miltenyi Biotec Business Overview
- 4.9.3 Miltenyi Biotec EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Miltenyi Biotec EGFR Antibody Product Portfolio
- 4.9.5 Miltenyi Biotec Recent Developments
- 4.10 Santa Cruz Biotechnology
- 4.10.1 Santa Cruz Biotechnology Company Information
- 4.10.2 Santa Cruz Biotechnology Business Overview
- 4.10.3 Santa Cruz Biotechnology EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Santa Cruz Biotechnology EGFR Antibody Product Portfolio
- 4.10.5 Santa Cruz Biotechnology Recent Developments
- 4.11 Merck
- 4.11.1 Merck Company Information
- 4.11.2 Merck Business Overview
- 4.11.3 Merck EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Merck EGFR Antibody Product Portfolio
- 4.11.5 Merck Recent Developments
5 Global EGFR Antibody Market Scenario by Region
- 5.1 Global EGFR Antibody Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global EGFR Antibody Sales by Region: 2021-2032
- 5.2.1 Global EGFR Antibody Sales by Region: 2021-2026
- 5.2.2 Global EGFR Antibody Sales by Region: 2027-2032
- 5.3 Global EGFR Antibody Revenue by Region: 2021-2032
- 5.3.1 Global EGFR Antibody Revenue by Region: 2021-2026
- 5.3.2 Global EGFR Antibody Revenue by Region: 2027-2032
- 5.4 North America EGFR Antibody Market Facts & Figures by Country
- 5.4.1 North America EGFR Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America EGFR Antibody Sales by Country (2021-2032)
- 5.4.3 North America EGFR Antibody Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe EGFR Antibody Market Facts & Figures by Country
- 5.5.1 Europe EGFR Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe EGFR Antibody Sales by Country (2021-2032)
- 5.5.3 Europe EGFR Antibody Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific EGFR Antibody Market Facts & Figures by Country
- 5.6.1 Asia Pacific EGFR Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific EGFR Antibody Sales by Country (2021-2032)
- 5.6.3 Asia Pacific EGFR Antibody Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America EGFR Antibody Market Facts & Figures by Country
- 5.7.1 South America EGFR Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America EGFR Antibody Sales by Country (2021-2032)
- 5.7.3 South America EGFR Antibody Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa EGFR Antibody Market Facts & Figures by Country
- 5.8.1 Middle East and Africa EGFR Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa EGFR Antibody Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa EGFR Antibody Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global EGFR Antibody Sales by Type (2021-2032)
- 6.1.1 Global EGFR Antibody Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global EGFR Antibody Sales Market Share by Type (2021-2032)
- 6.2 Global EGFR Antibody Revenue by Type (2021-2032)
- 6.2.1 Global EGFR Antibody Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global EGFR Antibody Revenue Market Share by Type (2021-2032)
- 6.3 Global EGFR Antibody Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global EGFR Antibody Sales by Application (2021-2032)
- 7.1.1 Global EGFR Antibody Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global EGFR Antibody Sales Market Share by Application (2021-2032)
- 7.2 Global EGFR Antibody Revenue by Application (2021-2032)
- 7.2.1 Global EGFR Antibody Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global EGFR Antibody Revenue Market Share by Application (2021-2032)
- 7.3 Global EGFR Antibody Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 EGFR Antibody Value Chain Analysis
- 8.1.1 EGFR Antibody Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 EGFR Antibody Production Mode & Process
- 8.2 EGFR Antibody Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 EGFR Antibody Distributors
- 8.2.3 EGFR Antibody Customers
9 Global EGFR Antibody Analyzing Market Dynamics
- 9.1 EGFR Antibody Industry Trends
- 9.2 EGFR Antibody Industry Drivers
- 9.3 EGFR Antibody Industry Opportunities and Challenges
- 9.4 EGFR Antibody Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst